Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to evaluate the
blood glucose control when using NovoMix® 50 up to 12 months after initiation subjects with
type 2 diabetes currently on a therapy with human biphasic insulin. An additional objective
is also to observe the different regimes of starting and maintaining the treatment with
NovoMix® 50 during one year.